内容摘要：The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

The withdrawal was first reported by Bloomberg News.This story was first published May 7, 2025. It was published again May 9, 2025, to correct that Means did her medical training at Stanford University, but not her surgical training. She was a surgical resident at Oregon Health and Science University but did not complete the program.

WASHINGTON (AP) — U.S. health officials on Friday endorsed the firstand identify patients who maythat can modestly slow the memory-destroying disease.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties. The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease.More than 6 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans.

The lower costs and convenience of a blood test could also help expand use of two new drugs, Leqembi and Kisunla, which have been shown to slightly slow the progression of Alzheimer’s by clearing amyloid from the brain. Doctors are required to test patients for the plaque before prescribing the drugs, which require regular IV infusions.Chaudhury said the centers also provided medical help to the community, and now people are struggling to find alternatives. Government hospitals and general medical facilities have some resources, but some in the LGBTQ+ community have said they feel uncomfortable with the way they are treated there.

“It is uncertain where they can go to get help in the coming days,” Chaudhury said. “I have so many people come with questions on where they can go, but I have no answer.”Simple Lama, a transgender sex worker, said access to medical help or items like condoms and lubricants is now far more challenging.

“It was easier and safer to go to the centers and clinics to get medical help and consultations,” Lama said. “But now it is difficult to go to big hospitals, and when we go to the regular hospitals, people look at us differently, treat us differently.”Sex work is illegal in Nepal, and sex workers are routinely harassed and chased by authorities. Transgender sex workers are generally more tolerated by the police because of the lobbying by LGBTQ+ rights groups pushing to stop harassment of their members.